Inmune Bio (INMB) Current Leases (2019 - 2025)
Historic Current Leases for Inmune Bio (INMB) over the last 7 years, with Q3 2025 value amounting to $457000.0.
- Inmune Bio's Current Leases rose 23851.85% to $457000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $457000.0, marking a year-over-year increase of 23851.85%. This contributed to the annual value of $140000.0 for FY2024, which is 1764.71% up from last year.
- Per Inmune Bio's latest filing, its Current Leases stood at $457000.0 for Q3 2025, which was up 23851.85% from $220000.0 recorded in Q2 2025.
- Over the past 5 years, Inmune Bio's Current Leases peaked at $457000.0 during Q3 2025, and registered a low of $23000.0 during Q1 2021.
- In the last 5 years, Inmune Bio's Current Leases had a median value of $113000.0 in 2022 and averaged $125263.2.
- In the last 5 years, Inmune Bio's Current Leases soared by 41798.56% in 2021 and then tumbled by 2638.89% in 2023.
- Inmune Bio's Current Leases (Quarter) stood at $72000.0 in 2021, then grew by 20.83% to $87000.0 in 2022, then surged by 36.78% to $119000.0 in 2023, then rose by 17.65% to $140000.0 in 2024, then surged by 226.43% to $457000.0 in 2025.
- Its Current Leases stands at $457000.0 for Q3 2025, versus $220000.0 for Q2 2025 and $146000.0 for Q1 2025.